Newborn drug dosing study uses leftover blood samples
NCT ID NCT04031183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the antibiotic metronidazole works in 171 newborns to find the best dose. Researchers used leftover blood or spinal fluid from routine tests, so no extra pokes were needed. The goal was to make sure enough babies get the right amount to fight infection without side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMERGENCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH St Brieuc
Saint-Brieuc, France
-
CH Vannes
Vannes, France
-
CHU d'Angers
Angers, France
-
CHU de Brest
Brest, France
-
CHU de Rennes
Rennes, France
-
CHU de Tours
Tours, France
-
Centre Robert Debré
Paris, France